FDA Drug Recalls

Recalls / Class III

Class IIID-0110-2018

Product

Methylphenidate Hydrochloride Extended-release Tablets, USP 27 mg, 100-count bottles, Rx Only, Trigen Laboratories, LLC. Bridgewater, NJ 08807, NDC 13811-707-10

Brand name
Methylphenidate Hydrochloride
Generic name
Methylphenidate Hydrochloride
Active ingredient
Methylphenidate Hydrochloride
Route
Oral
NDCs
13811-706, 13811-709, 13811-707, 13811-708, 13811-710
FDA application
ANDA205327
Affected lot / code info
Lot #: 170027A, Exp. 02/2019

Why it was recalled

Subpotent Drug

Recalling firm

Firm
Osmotica Pharmaceutical Corp
Manufacturer
Trigen Laboratories, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
895 Sawyer Rd, Marietta, Georgia 30062-2257

Distribution

Quantity
10064 bottles
Distribution pattern
Nationwide

Timeline

Recall initiated
2017-12-18
FDA classified
2017-12-20
Posted by FDA
2017-12-27
Terminated
2019-05-01
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0110-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: Methylphenidate Hydrochloride · FDA Drug Recalls